Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, announced that it has resubmitted to the FDA the New Drug Application...
Pozen Inc. announced the acquisition of Tribute Pharmaceuticals Canada Inc., a Canadian specialty pharmaceutical company, in a transaction valued at...
Aralez Pharmaceuticals Inc. announced that it acquired the U.S. and Canadian rights to Zontivity (vorapaxar), pursuant to an asset purchase...